Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitus

International Journal of Environmental Research and Public Health

Volumn 13, Issue 5, 2016, Pages

  Zhao, Liting ^a,b   Pu, Lingling ^a   Wei, Jingyu ^a   Li, Jinghua ^b   Wu, Jianquan ^c   Xin, Zhonghao ^a   Gao, Weina ^a   Guo, Changjiang ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b Pingjin Hospital   (China)

^c Tianjin Institute of Preventive Medicine   (China)

Author keywords

Antioxidant function; Brazilian green propolis; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; ALDEHYDE REDUCTASE; BRAZILIAN GREEN PROPOLIS; CARBONYL DERIVATIVE; GLUCOSE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; POLYPHENOL; PROPOLIS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; CYTOKINE; GLUCOSE BLOOD LEVEL; INSULIN;

ANTIOXIDANT; DIABETES; GLUCOSE; HEALTH IMPACT; METABOLISM;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; ANALYSIS; BLOOD; BRAZIL; DIABETES MELLITUS, TYPE 2; MIDDLE AGED;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; BRAZIL; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYPHENOLS; PROPOLIS;

EID: 84968796821     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13050498     Document Type: Article

References (45)

1. World Health Organization. Prevention of diabetes mellitus. In Report of a WHO Study Group; World Health Organization Technical Report: World Health Organization, Geneva, Switzerland, 1994.
2. International Diabetes Federation. IDF Diabetes Atlas, 6th ed.; International Diabetes Federation: Brussels, Belgium, 2014; Available online: http://www.idf.org/diabetesatlas (accessed on 3 March 2016).
3. AL-Waili, N.; Al-Ghamdi, A.; Ansari, J.M.; Al-Attal, Y.; Salom, K. Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures. Int. J. Med. Sci. 2012, 9, 793-800. [CrossRef] [PubMed]
4. Chan, G.C.; Cheung, K.W.; Sze, D.M. The immunomodulatory and anticancer properties of propolis. Clin. Rev. Allergy Immunol. 2013, 44, 262-273. [CrossRef] [PubMed]
5. Dobrowolski, J.W.; Vohora, S.B.; Sharma, K.; Shah, S.A.; Naqvi, S.A.; Dandiya, P.C. Antibacterial, antifungal, antiamoebic, antiinflammatory, antipyretic studies on propolis bee products. J. Ethnopharmacol. 1991, 35, 77-82. [CrossRef]
6. Gekker, G.; Hu, S.; Spivak, M.; Lokensgard, J.R.; Peterson, P.K. Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J. Ethnopharmacol. 2005, 102, 158-163. [CrossRef] [PubMed]
7. Orsi, R.O.; Fernandes, A.; Bankova, V.; Sforcin, J.M. The effects of Brazilian and Bulgarian propolis in vitro against Salmonella typhi and their synergism with antibiotics acting on the ribosome. Nat. Prod. Res. 2012, 26, 430-437. [CrossRef] [PubMed]
8. Sforcin, J.M. Propolis and the immune system: A review. J. Ethnopharmacol. 2007, 113, 1-14. [CrossRef] [PubMed]
9. Huang, S.; Zhang, C.P.; Wang, K.; Li, G.Q.; Hu, F.L. Recent advances in the chemical composition of propolis. Molecules 2014, 19, 19610-19632. [PubMed]
10. Kurek-Górecka, A.; Rzepecka-Stojko, A.; Górecki, M.; Stojko, J.; Sosada, M.; Swierczek-Zieba, G. Structure and antioxidant activity of polyphenols derived from propolis. Molecules 2013, 19, 78-101. [PubMed]
11. Volpi, N. Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis. Electrophoresis 2004, 25, 1872-1878. [PubMed]
12. Zhu, W.; Li, Y.H.; Chen, M.L.; Hu, F.L. Protective effects of Chinese and Brazilian propolis treatment against hepatorenal lesion in diabetic rats. Hum. Exp. Toxicol. 2011, 30, 1246-1255. [CrossRef] [PubMed]
13. Fukuda, T.; Fukui, M.; Tanaka, M.; Senmaru, T.; Iwase, H.; Yamazaki, M.; Aoi, W.; Inui, T.; Nakamura, N.; Marunaka, Y. Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study. Biomed. Rep. 2015, 3, 355-360. [PubMed]
14. Zhang, N.N.; Wu, J.Q.; Gao, W.N.; Wei, J.Y.; Pu, L.L.; Jiao, C.Y.; Guo, C.J.; Chang, H. The comparative study of oxidative stress in rats with diabetes mellitus by propolis from different origins. Chin. J. Food. Hyg. 2014, 1, 23-26.
15. Li, Y.; Chen, M.; Xuan, H.; Hu, F. Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid. Based. Compl. Alt. Med. 2012, 2012, 981896. [CrossRef] [PubMed]
16. Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention. China Food Composition 2009; Peking University Medical Press: Beijing, China, 2009.
17. Benzie, I.F.F.; Strain, J.J. The ferric reducing ability of plasma as a measure of antioxidant power: FRAP assay. Anal. Biochem. 1996, 239, 70-76. [CrossRef] [PubMed]
18. Ainsworth, E.A.; Gillespie, K.M. Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Nat. Protoc. 2007, 2, 875-877. [CrossRef] [PubMed]
19. Ohkawa, H.; Ohishi, N.; Kunio, Y. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358. [CrossRef]
20. Levine, R.L.; Wehr, N.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Determination of carbonyl groups in oxidized proteins. Methods. Mol. Biol. 2000, 99, 15-24. [PubMed]
21. Tangvarasittichai, S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes 2015, 6, 456-480. [CrossRef] [PubMed]
22. Giacco, F.; Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107, 1058-1070. [CrossRef] [PubMed]
23. Henriksen, E.J.; Diamond-Stanic, M.K.; Marchionne, E.M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 2011, 51, 993-999. [CrossRef] [PubMed]
24. Karunakaran, U.; Park, K.G. A systematic review of oxidative stress and safety of antioxidants in diabetes: Focus on islets and their defense. Diabetes Metab. J. 2013, 37, 106-112. [CrossRef] [PubMed]
25. Aouacheri, O.; Saka, S.; Krim, M.; Messaadia, A.; Maidi, I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can. J. Diabetes 2015, 39, 44-49. [CrossRef] [PubMed]
26. Maritim, A.C.; Sanders, R.A.; Watkins, J.B., 3rd. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24-38. [CrossRef] [PubMed]
27. Fu, M.X.; Requena, J.R.; Jenkins, A.J.; Lyons, T.J.; Baynes, J.W.; Thorpe, S.R. The advanced glycation end product, nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 1996, 271, 9982-9986. [PubMed]
28. Thornalley, P.J.; Langborg, A.; Minhas, H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 1999, 344, 109-116. [CrossRef] [PubMed]
29. Wells-Knecht, K.J.; Zyzak, D.V.; Litchfield, J.E.; Thorpe, S.R.; Baynes, J.W. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995, 34, 3702-3709. [CrossRef] [PubMed]
30. Ståhlman, M.; Fagerberg, B.; Adiels, M.; Ekroos, K.; Chapman, J.M.; Kontush, A.; Boren, J. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles. Biochim. Biophys. Acta 2013, 1831, 1609-1617. [CrossRef] [PubMed]
31. Dragan, S.; Andrica, F.; Serban, M.C.; Timar, R. Polyphenols-rich natural products for treatment of diabetes. Curr. Med. Chem. 2015, 22, 14-22. [CrossRef] [PubMed]
32. Palma-Duran, S.A.; Vlassopoulos, A.; Lean, M.; Govan, L.; Combet, E. Nutritional intervention and impact of polyphenol on glycohaemoglobin (HbA1c) in non-diabetic and type 2 diabetic subjects: Systematic review and meta-analysis. Crit. Rev. Food. Sci. Nutr. 2015. [CrossRef] [PubMed]
33. Gao, W.; Wu, J.; Wei, J.; Pu, L.; Guo, C.; Yang, J.; Yang, M.; Luo, H. Brazilian green propolis improves immune function in aged mice. J. Clin. Biochem. Nutr. 2014, 55, 7-10. [CrossRef] [PubMed]
34. El-Awady, M.S.; El-Agamy, D.S.; Suddek, G.M.; Nader, M.A. Propolis protects against high glucose-induced vascular endothelial dysfunction in isolated rat aorta. J. Physiol. Biochem. 2014, 70, 247-254. [CrossRef] [PubMed]
35. Al-Hariri, M.; Eldin, T.G.; Abu-Hozaifa, B.; Elnour, A. Glycemic control and anti-osteopathic effect of propolis in diabetic rats. Diabetes Metab. Syndr. Obes. 2011, 4, 377-384. [CrossRef] [PubMed]
36. Zhu, W.; Chen, M.; Shou, Q.; Li, Y.; Hu, F. Biological activities of Chinese propolis and Brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in rats. Evid. Based. Compl. Alt. Med. 2011, 2011, 468529. [CrossRef] [PubMed]
37. Hu, F.; Hepburn, H.R.; Xuan, H.; Chen, M.; Daya, S.; Radloff, S.E. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol. Res. 2005, 51, 147-152.
38. Margetic, S. Inflammation and haemostasis. Biochem. Med. 2012, 22, 49-62. [CrossRef]
39. Domingueti, C.P.; Dusse, L.M.; Carvalho, M.D.; de Sousa, L.P.; Gomes, K.B.; Fernandes, A.P. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J. Diabetes Complications. 2015, 30, 738-745. [CrossRef] [PubMed]
40. Scheller, J.; Chalaris, A.; Schmidt-Arras, D.; Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813, 878-888. [CrossRef] [PubMed]
41. Tilg, H.; Trehu, E.; Atkins, M.B.; Dinarello, C.A.; Mier, J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83, 113-118. [PubMed]
42. Bachiega, T.F.; Orsatti, C.L.; Pagliarone, A.C.; Sforcin, J.M. The effects of propolis and its isolated compounds on cytokine production by murine macrophages. Phytother. Res. 2012, 26, 1308-1313. [CrossRef] [PubMed]
43. Adeva, M.; González-Lucán, M.; Seco, M.; Donapetry, C. Enzymes involved in l-lactate metabolism in humans. Mitochondrion 2013, 13, 615-629. [CrossRef] [PubMed]
44. De La Cruz, J.P.; González-Correa, J.A.; Guerrero, A.; de la Cuesta, F.S. Pharmacological approach to diabetic retinopathy. Diabetes Metab. Res. Rev. 2004, 20, 91-113. [CrossRef] [PubMed]
45. Fiume, L.; Manerba, M.; Vettraino, M.; Di Stefano, G. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy. Future Med. Chem. 2014, 6, 429-445. [CrossRef] [PubMed]